2022
DOI: 10.1515/almed-2021-0076
|View full text |Cite
|
Sign up to set email alerts
|

Perfiles analíticos pre-configurados en insuficiencia cardiaca: implementación y uso en el Sistema Nacional de Salud Español

Abstract: Resumen Objetivos El uso de los perfiles analíticos pre-configurados (PAPs) en el contexto de la insuficiencia cardíaca (IC) podría ayudar a realizar un mejor manejo clínico y gestión eficiente del paciente. Los objetivos del estudio son entender el grado actual de implantación de los PAPs en el manejo de la IC en España y conocer la opinión de expertos sobre los mismos, prestando particular atención a los parámetros del metabolismo del hierro. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 36 publications
0
2
0
Order By: Relevance
“…These results highlight the importance of always determining iron metabolism in HF patients with or without renal disease. For this purpose, it is helpful to have pre-configured analytical profiles that include iron metabolism both in the clinic and hospital ward [37,38], as well as in the development of strong cardio-renal units [39], to prevent HF patients from reaching advanced stages of renal failure, where the benefit of treatment could be smaller. The final aim is to try to offer our patients the best treatment of comorbidities in less advanced stages of cardiorenal syndrome.…”
Section: Discussionmentioning
confidence: 99%
“…These results highlight the importance of always determining iron metabolism in HF patients with or without renal disease. For this purpose, it is helpful to have pre-configured analytical profiles that include iron metabolism both in the clinic and hospital ward [37,38], as well as in the development of strong cardio-renal units [39], to prevent HF patients from reaching advanced stages of renal failure, where the benefit of treatment could be smaller. The final aim is to try to offer our patients the best treatment of comorbidities in less advanced stages of cardiorenal syndrome.…”
Section: Discussionmentioning
confidence: 99%
“…All patients had a predefined laboratory test panel performed on the day following admission that included iron parameters (ferritin levels and transferrin saturation index [TSAT]) [11,12]. ID was diagnosed and treated with FCM according to the criteria established in the ESC HF guidelines (3) (ferritin levels < 100 µg/L or 100-300 µg/L with TSAT < 20%).…”
Section: Study and Patient Cohortmentioning
confidence: 99%